Our People
Our Management Team
A dynamic management team has been leading our early development initiatives.
Dr. Wayne Danter, MD, FRCPC - President and Chief Scientific Officer
Internist/Cardiologist
Research fellowship training in Clinical Pharmacology
Inventor of the CHEMSASŪ process
Dr. Kathleen Ferguson, MD, FRCPC - Secretary Treasurer
Respirologist and Sleep Physician
Clinical Researcher
Mr. John Drake - Chief Executive Officer
Mr. Gene Kelly - Chief Financial Officer
Mr. Dean Gendron - Vice President - Strategic Relationships
Mr. Michael Barr - Director of Marketing and Business Development
Our Board of Directors
Dr. Wayne Danter
Dr. Kathy Ferguson
Mr. Dean Gendron
Mr. Bruno Maruzzo
Dr. Rainer Engelhardt
Mr. Mark Hlady
Our Scientific Advisory Board
Dr. Brigitte LeBreton
Molecular Biologist
Former Executive Vice President at Procyon Biopharma
Dr. Jim Koropatnick
Director - Cancer Research Labs - London Regional Cancer Centre
Dr. Henrik Hansen
Director of Chemistry - Resverlogix